𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of cystemustine in metastatic colorectal carcinoma

✍ Scribed by Fumoleau, P.; Kerbrat, P.; Adenis, A.; Rebattu, P.; Roche, H.; Chevallier, B.; Chollet, Ph.; Krakowski, I.; Lentz, M.A.

Book ID
122685399
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
383 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of oral S-1 for treatment
Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma
✍ Kuniaki Shirao; Atsushi Ohtsu; Hideho Takada; Yasushi Mitachi; Kosei Hirakawa; N πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Abstract ## BACKGROUND The goal of the current study was to evaluate the objective response rate and toxicity associated with the oral fluoropyrimidine S‐1 (a combination of tegafur, 5‐chloro‐2,4‐dihydroxypyridine, and potassium oxonate) in patients with previously untreated metastatic colorect

A phase II study of chemotherapy of meta
A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin
✍ Robert P. Whitehead; Thomas R. Fleming; John S. Macdonald; Frederick R. Ahmann; πŸ“‚ Article πŸ“… 1991 πŸ› Springer US 🌐 English βš– 205 KB

The combination of 5-fluorouracil and cisplatin has shown encouraging results in single institution pilot studies in colorectal carcinoma. This phase II SWOG study was undertaken to further evaluate this treatment. Cisplatin was administered at a dose of 60 mg/M2 IV day 1, repeated every 21 days. 5-